dr. bruix discusses the application of regorafenib in hcc
Published 7 years ago • 62 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
2:04
dr. bruix on regorafenib in second-line hcc
-
2:20
dr. bruix discusses the updated findings of the resorce trial in hcc
-
1:28
dr. jordi bruix on efficacy and safety of regorafenib in hcc after sorafenib
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
1:03
dr. musher discusses the role of regorafenib in advanced hcc
-
1:11
dr. bruix discusses progress of second-line treatment in hcc
-
8:29
incorporating regorafenib in the hcc treatment landscape
-
2:31
dr. bruix on the phase iii resorce trial in hcc
-
7:01
global use of regorafenib in hcc
-
0:49
dr. daniele on impact of regorafenib in hcc
-
7:09
global use of regorafenib in hcc
-
4:14
the use of regorafenib in clinical practice
-
1:11
regorafenib vs sorafenib in the treatment of liver cancer
-
3:48
clinical experience with regorafenib in hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
4:30
regorafenib following first-line systemic therapy in hcc
-
1:14
dr. abou-alfa on the ongoing impact and role of regorafenib in hcc